Custom embryo transfer after doing tests in to improve IVF outcome

Personalized Embryo transfer(ET) after combination of available modalities CD138,Preimplantation Genetic Diseases (PGD),Endometrial Receptivity Array (ERA)to improve in-vitro fertilization(IVF) success. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092870

Enrollment

Registered

2025-08-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N972- Female infertility of uterine origin

Interventions

Intervention1: Pregentic testing on the Embryos and ERA and CD138 testing: Pregentic testing is done on Blastocyst of mebryos and asses the aneuploidy and Endometrial sample is taken to Assess the rec

Eligibility

Inclusion criteria

Inclusion criteria: female aged 21 to 50 years. women with subfertility history of implantation failure,recurrent miscarriage. those willing to get enrolled in vitro fertilization and give consent for the study

Exclusion criteria

Exclusion criteria: Male factor subfertility Age over 50 poor ovarian reserve severe endometrial abnormalities like polyp,fibroids. known genetic disorders

Design outcomes

Primary

Measure	Time frame
combining CD138,Pregenetic diagnosis, Endometrial receptivity array in personalized embryo transfer will improve the outcomeTimepoint: 8 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactH s Deeksha

DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH

dr.kamleshchaudhari@gmail.com932568673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026